XOMA Royalty Stock Quote XOMA - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

30.86

Bid

30.26

Ask

31.00

Volume

13,013

30.00 Day's Range 30.98

14.27 52 Week Range 31.93

Market Cap

361.2M

Previous Close

30.38

Open

30.40

Last Trade

141

30.86

(priorref)

Last Trade Time

16:02:24

Financial Volume

$ 395,898

VWAP

30.4233

Average Volume (3m)

21,401

Shares Outstanding

11,704,467

Dividend Yield

PE Ratio

-8.83

Earnings Per Share (EPS)

-3.49

Revenue

4.76M

Net Profit

-40.83M

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.xoma.com

Headquarters

Wilmington, Delaware, USA

Founded

XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XOMA. The last closing price for XOMA Royalty was $30.38. Over the last year, XOMA Royalty shares have traded in a share price range of $ 14.27 to $ 31.93.

XOMA Royalty currently has 11,704,467 shares outstanding. The market capitalization of XOMA Royalty is $355.58 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -8.83.

FeaturedNorth Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty has acquired 50 percent of Twist’s existing royalty and milestone economics for $15 million XOMA Royalty’s portfolio now holds over 100 assets ranging from revenue-generating...

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.35	4.57472043375	29.51	31.93	26.74	24259	30.4024664	CS
4	3.33	12.0958953869	27.53	31.93	26.74	17073	29.23406483	CS
12	7.04	29.5549958018	23.82	31.93	22.7	21401	28.13463814	CS
26	6.1	24.6365105008	24.76	31.93	21.27	19714	27.04373459	CS
52	12.49	67.991290147	18.37	31.93	14.27	21150	23.60512284	CS
156	5.54	21.8799368088	25.32	32.085	13.48	29109	20.79806858	CS
260	11.16	56.6497461929	19.7	46.32	13.48	35774	24.36577459	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
QNSTQuinStreet Inc	$ 25.90 (28.22%)	11.03k
BCOVBrightcove Inc	$ 2.74 (28.04%)	10.06k
PTIRGraniteShares 2X Long PLTR Daily ETF	$ 53.58 (22.58%)	63.22k
BNOXBionomics Ltd	$ 0.233 (21.84%)	5.06M
ALABAstera Labs Inc	$ 83.17 (19.41%)	335.21k
MQMarqeta Inc	$ 4.351 (-26.87%)	1.38M
LSCCLattice Semiconductor Corp	$ 46.70 (-10.00%)	215.64k
PRPLPurple Innovation Inc	$ 0.8501 (-9.56%)	95.93k
ABCLAbCellera Biologics Inc	$ 2.62 (-9.34%)	76.29k
CRUSCirrus Logic Inc	$ 101.00 (-8.70%)	39.98k
IDAIT Stamp Inc	$ 0.2768 (12.98%)	11.75M
BNOXBionomics Ltd	$ 0.233 (21.84%)	5.06M
ELABElevai Labs Inc	$ 0.0202 (0.50%)	4.08M
NVDANVIDIA Corporation	$ 136.51 (0.34%)	3.67M
SPPLSIMPPLE Ltd	$ 1.22 (3.39%)	2.65M